| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.50B | -7.4% | -0.4% |
| Cost of Revenue | $1.26B | -5.6% | +3.9% |
| Gross Profit | $233.0M | -16.2% | -18.5% |
| R&D Expense | $26.0M | -7.1% | -10.3% |
| SG&A Expense | $109.0M | -75.1% | -19.3% |
| Interest Expense | $68.0M | +1.5% | -1.4% |
| Pre-tax Income | $51.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $613.0M | +22.1% | +2.9% |
| Accounts Receivable | $817.0M | +0.5% | -1.0% |
| Inventory | $1.55B | -0.7% | +7.6% |
| Current Assets | $3.21B | +3.5% | +4.1% |
| Total Assets | $7.57B | +1.1% | +1.4% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $127.0M | — | — |
| Capital Expenditures | $168.0M | — | — |
| Investing Cash Flow | -$163.0M | — | — |
| Financing Cash Flow | -$89.0M | — | — |
| Free Cash Flow | -$41.0M | — | — |
| +119.5% |
| +270.0% |
| Income Tax | -$9.0M | -107.6% | -200.0% |
| Net Income | $60.0M | +115.7% | +322.2% |
| EPS (Basic) | $0.40 | +115.7% | +322.2% |
| EPS (Diluted) | $0.40 | +115.7% | +322.2% |
| $1.88B |
| +1.6% |
| +5.8% |
| Long-term Debt | $4.10B | -0.1% | +2.8% |
| Total Liabilities | $7.27B | +0.3% | +6.8% |
| Stockholders' Equity | $298.0M | +25.7% | -54.6% |